Diagnostic Testing of STDs Market, By Test Type (Chlamydia, Gonorrhea, Syphilis, HIV, HPV+pap smear, HSV, and Chancroid), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Description

Diagnostic Testing Of Stds Market is estimated to be valued at USD 12.49 Bn in 2025 and is expected to reach USD 23.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 12.49 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.60%	2032 Value Projection:	USD 23.73 Bn

Sexually Transmitted Diseases (STDs) are diseases that spread from person-to-person through sexual contact. Early identification or diagnosis of STDs can help stop further transmission. Laboratory tests can identify the cause and detect co-infections through blood tests, urine samples, swab tests, lumbar puncture, and fluids samples. Testing for a disease in someone who doesn't have symptoms is called screening. The screening can be done for a variety of infections like HIV, hepatitis B, chlamydia, syphilis, gonorrhea, and hepatitis C. Cervical cancer is often caused by certain strains of HPV. Treatment of STDs can be done by antibiotics and antiviral drugs which prevents the further spread of disease.

Market Dynamics

The increasing prevalence of STDs, government fundings for the treatment and management of STDs is expected to drive the global diagnostic testing of STDs market growth. For instance, on February 2, 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based biotechnology company, launched rapid test kits for sexually transmitted diseases including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and syphilis. Among these tests, HIV 1/2 Ab, and HCV Ab are rapid tests for the detection of antibodies specific to HIV-1, HIV-2, and HCV respectively, while the syphilis antibody test detects antibodies (IgG, IgA, and IgM) to aid in the diagnosis of syphilis.

Key features of the study

This report provides an in-depth analysis of the global diagnostic testing of STDs market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global diagnostic testing of STDs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics.
The global diagnostic testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic testing of STDs market.

Market Segmentation

Global Diagnostic Testing of STDs Market, By Test Type
- Chlamydia
- Gonorrhea
- Syphilis
- HIV
- HPV+pap smear
- HSV
- Chancroid
Global Diagnostic Testing of STDs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
- Vela Diagnostics USA Inc.
- Roche Holdings AG
- Alere, Inc.
- Becton Dickinson & Company
- bioMerieux
- Danaher Corporation (Beckman Coulter)
- Hologic, Inc.
- binx health
- Chembio Diagnostics
- Pinpoint Science Inc.
- bioLytical Laboratories.

Product Code: CMI3917

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Diagnostic Testing of STDs Market, By Test Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Chlamydia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gonorrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Syphilis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HPV+ pap smear
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chancroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Diagnostic Testing of STDs Market, By Region, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

6. Competitive Landscape

Vela Diagnostics USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Roche Holdings AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Alere, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton Dickinson & Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Danaher Corporation (Beckman Coulter)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
binx health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chembio Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pinpoint Science Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioLytical Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

7. Section

Research Methodology
About Us